Genetic Technologies Ltd - stock earnings
GENE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -4.4 million USD | 2.7 million USD |
| 2023Q2 | -4.2 million USD | 3.0 million USD |
| 2023Q1 | -2.1 million USD | 1.8 million USD |
| 2022Q4 | -3.7 million USD | 2.8 million USD |
| 2022Q3 | -1.8 million USD | 1.6 million USD |
| 2022Q2 | -1.6 million USD | 3.6 million USD |
| 2022Q1 | -1.6 million USD | 3.6 million USD |
| 2021Q4 | -1.9 million USD | 1.0 million USD |
| 2021Q3 | -1.9 million USD | 1.0 million USD |
| 2021Q2 | -2.7 million USD | 80753 USD |
| 2021Q1 | -1.8 million AUD | 52059 AUD |
| 2020Q4 | -1.3 million USD | 6328 USD |
| 2020Q3 | -1.2 million USD | 3326 USD |
| 2020Q2 | -1.2 million USD | 3201 USD |
| 2019Q4 | -38448 USD | 8 USD |
| 2019Q3 | -4.4 million USD | 17266 USD |
| 2019Q2 | -44655 USD | 95 USD |
| 2019Q1 | -54427 USD | 116 USD |
| 2018Q4 | -47437 USD | 279 USD |
| 2018Q3 | -3.9 million USD | 136342 USD |
| 2018Q2 | -230917 USD | 9758 USD |
| 2018Q1 | -637433 USD | 26937 USD |
| 2017Q4 | -1.6 million USD | 28537 USD |
| 2017Q3 | -6.6 million USD | 406835 USD |
| 2017Q2 | -6.4 million USD | 100712 USD |
| 2017Q1 | -1.7 million USD | 288458 USD |
| 2016Q4 | 2.9 million USD | 192612 USD |
| 2016Q3 | -6.5 million USD | 629035 USD |
| 2016Q2 | -6.3 million USD | 267496 USD |
| 2016Q1 | ? USD | 366089 USD |
| 2015Q4 | ? USD | 348198 USD |
| 2015Q3 | -6.2 million USD | 1.4 million USD |
| 2015Q2 | -6.8 million USD | 783214 USD |
| 2015Q1 | ? USD | 1.0 million USD |
| 2014Q4 | ? USD | 1.1 million USD |
| 2014Q2 | -9.5 million USD | 2.8 million USD |
| 2014Q1 | ? USD | 2.0 million USD |
| 2013Q4 | ? USD | 1.9 million USD |
| 2013Q2 | ? USD | 1.8 million USD |
| 2013Q1 | ? USD | 5.7 million USD |
| 2012Q4 | ? USD | 5.7 million USD |
| 2012Q2 | ? USD | 2.6 million USD |
| 2012Q1 | ? USD | 3.9 million USD |
| 2011Q4 | ? USD | 3.8 million USD |
| 2011Q2 | 1.0 million USD | 5.7 million USD |
| 2011Q1 | -4.5 million USD | 14.7 million USD |
| 2010Q4 | 4.4 million USD | 14.5 million USD |
| 2010Q2 | ? USD | 3.3 million USD |
| 2010Q1 | ? USD | 3.8 million USD |
| 2009Q4 | ? USD | 3.8 million USD |
| 2009Q2 | ? USD | 3.9 million USD |
| 2009Q1 | ? USD | 2.8 million USD |
| 2008Q4 | ? USD | 2.8 million USD |
| 2008Q3 | -2.0 million USD | 2.6 million USD |
| 2008Q2 | -2.4 million USD | 3.2 million USD |
| 2008Q1 | -2.3 million USD | 6.1 million USD |
| 2007Q4 | -198273 USD | 4.0 million USD |
| 2007Q3 | 1.0 million USD | 5.6 million USD |
| 2007Q2 | -192454 USD | 3.7 million USD |
| 2007Q1 | 1.1 million USD | 3.4 million USD |
| 2006Q4 | -2.1 million USD | 1.5 million USD |
| 2006Q3 | -894878 USD | 1.6 million USD |
| 2006Q2 | -2.6 million USD | 2.0 million USD |
| 2006Q1 | -1.0 million USD | 1.8 million USD |
| 2005Q4 | -1.1 million USD | 2.5 million USD |
| 2005Q3 | -371600 USD | -786799 USD |
| 2005Q2 | -372203 USD | -788076 USD |
| 2005Q1 | -5.0 million USD | 2.7 million USD |
| 2004Q4 | -206797 USD | 2.7 million USD |
| 2004Q3 | -206316 USD | 2.7 million USD |
| 2004Q2 | ? USD | 869038 USD |
| 2004Q1 | ? USD | 1.1 million USD |
| 2003Q4 | ? USD | 1.1 million USD |
| 2003Q2 | ? USD | 2.9 million USD |
GENE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.8 million USD | 5.8 million USD |
| 2022 | -4.9 million USD | 4.7 million USD |
| 2021 | -5.4 million USD | 90394 USD |
| 2020 | -4.4 million USD | 6807 USD |
| 2019 | -4.8 million USD | 17823 USD |
| 2018 | -4.0 million USD | 139048 USD |
| 2017 | -6.5 million USD | 398625 USD |
| 2016 | -6.3 million USD | 616127 USD |
| 2015 | -6.8 million USD | 1.5 million USD |
| 2014 | -9.5 million USD | 4.3 million USD |
| 2013 | -8.7 million USD | 3.1 million USD |
| 2012 | -5.3 million USD | 11.4 million USD |
| 2011 | 972966 USD | 19.5 million USD |
| 2010 | -7.9 million USD | 8.2 million USD |
| 2009 | -7.8 million USD | 5.4 million USD |
| 2008 | -5.2 million USD | 15.1 million USD |
| 2007 | -1.4 million USD | 11.7 million USD |
| 2006 | -4.0 million USD | 7.4 million USD |
| 2005 | -5.7 million USD | 7.2 million USD |
| 2004 | -4.8 million USD | 2.6 million USD |
| 2003 | -2.9 million USD | 6.2 million USD |
| 2002 | -5.0 million USD | 7.4 million USD |
| 2001 | -1.7 million USD | 2.9 million USD |
| 2000 | -1.5 million USD | 2.4 million USD |
GENE
Price: $2.22
52 week price:
Earnings Per Share: -0.15 USD
P/E Ratio: -14.82
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 666231
Ebitda: -5.8 millionMarket Capitalization: 10.7 million